enarodustat
Ligand Summary
Enarodustat is an orally active inhibitor of hypoxia inducible factor-proly hydroxylase (HIF-PH) being developed for the treatment of anaemia associated with chronic kidney disease (CKD).
ChEMBL: CHEMBL4297619
DrugCentral: 5427
LyCHI: 8CXRSW3SQNMT
Target Activities
3 Activities
Items per page:
1 – 3 of 3
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
Ki | INHIBITOR | |||||
Ki | INHIBITOR | |||||
Ki | INHIBITOR | |||||